IP Verse

Competitive analysis in Nucleic Acids industry

Top companies filing patent oppositions

Company
SANOFI
Total Oppositions
8
Company
WITHERS & ROGERS LLP
Total Oppositions
8
Company
BECKMAN COULTER, INC.
Total Oppositions
7
Company
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
Total Oppositions
6
Company
BIONTECH SE
Total Oppositions
6
Company
JAMES POOLE LIMITED
Total Oppositions
5
Company
PATENT BOUTIQUE LLP
Total Oppositions
5
Company
BOULT WADE TENNANT LLP
Total Oppositions
4
Company
PFIZER INC.
Total Oppositions
4
Company
ETHERNA IMMUNOTHERAPIES NV
Total Oppositions
4

Top companies facing patent oppositions

Company
MODERNATX, INC.
Total Oppositions
46
Company
MODERNA THERAPEUTICS, INC.
Total Oppositions
14
Company
GENEOHM SCIENCES, INC.
Total Oppositions
8
Company
ILLUMINA CAMBRIDGE LIMITED
Total Oppositions
8
Company
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Total Oppositions
8
Company
SILENCE THERAPEUTICS GMBH
Total Oppositions
7
Company
THE GENERAL HOSPITAL CORPORATION
Total Oppositions
7
Company
TRANSLATE BIO, INC.
Total Oppositions
6
Company
DANA-FARBER CANCER INSTITUTE, INC.
Total Oppositions
6
Company
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Total Oppositions
5

Latest patents granted in the Nucleic Acids industry

Patent:
EP3431485
Grant Date:
Sep 4, 2024
Title:
Engineered Nucleic Acids And Methods Of Use Thereof
Applicant:
MODERNATX, INC.
Patent:
EP2971125
Grant Date:
Nov 22, 2023
Title:
Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
Applicant:
THE GENERAL HOSPITAL CORPORATION
Patent:
EP4140491
Grant Date:
Sep 13, 2023
Title:
Compositions And Methods For Synthesizing 5'-Capped Rnas
Applicant:
TRILINK BIOTECHNOLOGIES, LLC
Patent:
EP3870594
Grant Date:
Aug 2, 2023
Title:
Process For The Purification Of Oligonucleotides
Applicant:
F. HOFFMANN-LA ROCHE AG
Patent:
EP2999784
Grant Date:
Nov 23, 2022
Title:
Targeted Transposition For Use In Epigenetic Studies
Applicant:
ACTIVE MOTIF, INC.
Patent:
EP2877854
Grant Date:
Sep 7, 2022
Title:
Fusion Proteins And Methods Thereof
Applicant:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Patent:
EP3603679
Grant Date:
Aug 10, 2022
Title:
Rna-Guideded Transcriptional Regulation
Applicant:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Patent:
EP3122870
Grant Date:
Jun 29, 2022
Title:
Methods And Genetic Systems For Cell Engineering
Applicant:
GINKGO BIOWORKS INC.
Patent:
EP3590949
Grant Date:
May 18, 2022
Title:
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
Applicant:
MODERNATX, INC.
Patent:
EP3656860
Grant Date:
Apr 20, 2022
Title:
Angiopoietin-Like 3 (Angptl3) Irna Compositions And Methods Of Use Thereof
Applicant:
ALNYLAM PHARMACEUTICALS, INC.

Top patents facing oppositions in Nucleic Acids industry

Patent
EP3682905
Grant Date
Dec 1, 2021
Title
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
Applicant
MODERNATX, INC.
Oppositions
20
Patent
EP2791160
Grant Date
Mar 2, 2022
Title
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Applicant
MODERNATX, INC.
Oppositions
20
Patent
EP3590949
Grant Date
May 18, 2022
Title
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
Applicant
MODERNATX, INC.
Oppositions
9
Patent
EP1857547
Grant Date
Dec 2, 2020
Title
Further Novel Forms Of Interfering Rna Molecules
Applicant
SILENCE THERAPEUTICS GMBH
Oppositions
9
Patent
EP3492109
Grant Date
Mar 4, 2020
Title
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
Applicant
MODERNATX, INC.
Oppositions
8
Patent
EP2258847
Grant Date
Jul 1, 2020
Title
Futher Novel Forms Of Interfering Rna Molecules
Applicant
SILENCE THERAPEUTICS GMBH
Oppositions
6
Patent
EP2506857
Grant Date
Feb 14, 2018
Title
Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases
Applicant
SHIRE HUMAN GENETIC THERAPIES
Oppositions
6
Patent
EP2279254
Grant Date
Jul 5, 2017
Title
Novel Lipid Formulations For Nucleic Acid Delivery
Applicant
ARBUTUS BIOPHARMA CORPORATION
Oppositions
4
Patent
EP2439285
Grant Date
May 8, 2019
Title
Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments
Applicant
THE GENERAL HOSPITAL CORPORATION
Oppositions
4
Patent
EP2325644
Grant Date
Jul 29, 2020
Title
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xii
Applicant
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Oppositions
4

Need more information?

Feel free to send us a message here and we will get back to you